(CCKRF)
- Previous Close
0.00 - Open
-- - Bid --
- Ask --
- Day's Range
-- - 52 Week Range
18.65 - 19.30 - Volume
-- - Avg. Volume
23 - Market Cap (intraday)
5.101B - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
26.64 - EPS (TTM)
0.70 - Earnings Date Apr 16, 2025
- Forward Dividend & Yield 0.13 (0.68%)
- Ex-Dividend Date Jul 2, 2025
- 1y Target Est
--
Clicks Group Limited, together with its subsidiaries, operates as a health, wellness, and beauty retailer in South Africa and internationally. It operates through two segments: Retail and Distribution. The company retails pharmacy, health, and beauty through stores, and in-store pharmacies for the middle to upper income markets under the Clicks brand name. It also offers various range of mother and baby products including baby hardware, accessories, health, foods, diapers and wipes, and baby toiletries under the Clicks Baby brand; beauty therapy, grooming, and ethnic hair care under the Sorbet brand name; diabetic clinic, travel clinic, and wounds management practice under the M-KEM brand; and naturally-inspired beauty products under The Body Shop brand name. In addition, the company involved in the wholesale and supply of pharmaceutical products to retail pharmacies, private hospitals, dispensing doctors, and retail health stores under the UPD brand. The company was formerly known as New Clicks Holdings Limited and changed its name to Clicks Group Limited in June 2009. Clicks Group Limited was founded in 1968 and is headquartered in Cape Town, South Africa.
www.clicksgroup.co.za19,729
Full Time Employees
August 31
Fiscal Year Ends
Sector
Industry
Recent News: CCKRF
View MorePerformance Overview: CCKRF
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is All Share Index (^J203.JO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CCKRF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CCKRF
View MoreValuation Measures
Market Cap
5.20B
Enterprise Value
5.33B
Trailing P/E
26.63
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.71
Price/Book (mrq)
12.44
Enterprise Value/Revenue
2.05
Enterprise Value/EBITDA
15.20
Financial Highlights
Profitability and Income Statement
Profit Margin
6.41%
Return on Assets (ttm)
14.01%
Return on Equity (ttm)
51.61%
Revenue (ttm)
46.8B
Net Income Avi to Common (ttm)
3B
Diluted EPS (ttm)
0.70
Balance Sheet and Cash Flow
Total Cash (mrq)
1.72B
Total Debt/Equity (mrq)
64.10%
Levered Free Cash Flow (ttm)
3.23B